|
|
LLR Partners closes sixth fund at USD1.8bn | Tue | 20 Oct 2020, 12:14 | LLR Partners, a lower middle market private equity firm, has held the final closing of LLR Equity Partners VI (LLR 6) at USD1.8 billion, inclusive of the General Partner’s commitment. |
|
|
Thoma Bravo to acquire AxiomSL | Tue | 20 Oct 2020, 12:14 | Tech-focused private equity firm Thoma Bravo is to acquire a controlling interest in AxiomSL, a provider of cloud-enabled risk management and regulatory solutions for banking, investment management, broker dealers and commodity trading institutions. |
|
|
|
|
Aurelius to acquire GKN Wheels & Structures | Tue | 20 Oct 2020, 12:14 | Aurelius Equity Opportunities SE & Co has agreed to acquire GKN Wheels & Structures from GKN. The transaction is expected to complete in November and is conditional on receiving anti-trust approval. |
|
|
GI Partners to acquire Vast Broadband | Tue | 20 Oct 2020, 12:14 | Vast Broadband (Vast), a provider of gigabit-speed broadband, video, and phone in South Dakota and Minnesota, is to be acquired by GI Partners, a US-based investor in data infrastructure businesses, in partnership with industry veteran Rich Fish. |
|
|
Kainos Capital to acquire Nutrisystem | Tue | 20 Oct 2020, 12:14 | Kainos Capital, a private equity firm focused exclusively on the food and consumer industry, is to acquire Nutrisystem, a direct-to-consumer nutrition and weight management brand, from Tivity Health for USD575 million. |
|
|
CapVest acquires Datasite | Tue | 20 Oct 2020, 12:14 | Funds managed by CapVest Partners (CapVest), an international private equity firm, have agreed to acquire Datasite Global Corporation (Datasite), a global Software-as-a-Service (SaaS) provider across the deal lifecycle. |
|
|
Gen II Fund Services has appointed Head of Strategic Business Development | Tue | 20 Oct 2020, 12:14 | Gen II Fund Services (Gen II), an independent private equity fund administrator, has appointed Robert Caporale as Head of Strategic Business Development. Caporale, a fund administration and alternative investments executive, will focus on developing strategic client partnerships and acquisition opportunities. |
|
|
Earth Capital adds to investment team | Tue | 20 Oct 2020, 12:14 | Sustainable investments specialist Earth Capital has extended equity ownership of the business and reshaped its European investment team as demand for impact investment soars, driven principally by increasing concerns about climate change. |
|
|
Genstar-backed Prometheus Group acquires Utopia Global | Tue | 20 Oct 2020, 12:14 | Prometheus Group, a global provider of asset management operations and optimisation software, has acquired Utopia Global, a data solutions company known for its end-to-end data quality, data migration and data governance solutions. |
|
|
|
|
|
|
SEEIT acquires Swedish regulated gas distribution network | Tue | 20 Oct 2020, 12:14 | SDCL Energy Efficiency Income Trust (SEEIT), the first UK-listed investment company of its kind to invest exclusively in the energy efficiency sector, has agreed to acquire a 100 per cent interest in Värtan Gas Stockholm AB (VGSAB), the ultimate owner of the established, operational and regulated gas distribution network for Stockholm, Sweden, involving an equity investment of approximately GBP100 million. |
|
|
Mid Europa to sell equity interest in Waberer's | Tue | 20 Oct 2020, 12:14 | Mid Europa Partners, a private equity investor focused on Central and Eastern Europe, is to sell 24 per cent of the issued share capital in Waberer’s International Nyrt (Waberer’s) to Trevelin Holding Zrt (Indotek). |
|
|
Tikehau Capital makes new senior UK appointments | Tue | 20 Oct 2020, 12:14 | Tikehau Capital, an alternative asset management and investment group, has appointed Carmen Alonso as Head of the United Kingdom and Peter Cirenza is promoted to Chairman of the United Kingdom as well as Chairman of Tactical Strategies. |
|
|
Topas Therapeutics raises EUR22m in Series B financing | Tue | 20 Oct 2020, 12:14 | Topas Therapeutics (Topas), a Hamburg, Germany-based private platform company leveraging the natural immune tolerance induction capabilities of the liver, has closed a EUR22 million (~USD26 million) Series B financing round. |
|
|
|
|
|
Copyright © 2020 All Rights Reservered About | Disclaimer Unsubscribe me from the list |
|